President, Early Technologies
Under Chuck’s leadership, Early Technologies is responsible for developing or acquiring disruptive solutions that improve clinical and economic outcomes for patients, providers and payers in today’s cost sensitive environment.
Prior to joining Covidien in 2013, Chuck was President and CEO at IntraPace, Inc., an early stage medical device company treating obesity. Before IntraPace, Chuck spent 24 years at Medtronic in various regional, business unit and corporate leadership roles as the company went from a $250 million pacemaker company to a diversified medical technology enterprise with over $10 billion in revenues.
Chuck received a Master’s of Business Administration at the J.L. Kellogg Graduate School of Management, Northwestern University, as well as a Bachelor’s of Arts at Bradley University.